These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 12856800

  • 1. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G, Hansen A, Prestwood KM.
    Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
    [Abstract] [Full Text] [Related]

  • 2. Lack of effect of short-term micronized progesterone on bone turnover in postmenopausal women.
    Ikram Z, Dulipsingh L, Prestwood KM.
    J Womens Health Gend Based Med; 1999 Sep; 8(7):973-8. PubMed ID: 10534300
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of low dose micronized 17ss-estradiol on bone turnover, sex hormone levels, and side effects in older women: a randomized, double blind, placebo-controlled study.
    Prestwood KM, Kenny AM, Unson C, Kulldorff M.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4462-9. PubMed ID: 11134094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S, Panyakhamlerd K, Treratanachat S, Taechakraichana N.
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy.
    Tobias JH, Clarke S, Mitchell K, Robins S, Amer H, Fraser WD.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1194-8. PubMed ID: 11238508
    [Abstract] [Full Text] [Related]

  • 13. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
    Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Pons F, Martínez de Osaba MJ, Echevarría M, Ballesta AM, Muñoz-Gómez J.
    Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
    [Abstract] [Full Text] [Related]

  • 14. Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover.
    de Valk-de Roo GW, Netelenbos JC, Peters-Muller IR, Voetberg GA, van de Weijer PH, Bouman AA, Popp-Snijders C, Kenemans P.
    Maturitas; 1997 Dec 15; 28(2):153-62. PubMed ID: 9522323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density.
    Miller BE, De Souza MJ, Slade K, Luciano AA.
    Menopause; 2000 Dec 15; 7(5):318-26. PubMed ID: 10993031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W, Petersdorf LI, Junker R, Schulte H, Ebert C, Von Eckardstein A.
    Clin Endocrinol (Oxf); 1999 Nov 15; 51(5):643-51. PubMed ID: 10594527
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.